BEUDAMED
    FDA Adverse Event Injury Summary report: N

    HET

    MDR report key: 14434834 · Received May 19, 2022

    Report

    Report Number
    1717344-2022-00605
    Event Type
    Injury
    Date Received
    May 19, 2022
    Date of Event
    April 21, 2022
    Report Date
    August 15, 2022
    Manufacturer
    COVIDIEN MFG DC BOULDER
    Product Code
    GEI
    UDI-DI
    10884521511132
    PMA / PMN Number
    K140422
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    PA, US
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

    Additional Manufacturer Narrative · 0

    ADDITIONAL INFORMATION: B5, D3 (MFR NAME, STREET 1, MFR CITY, MFR REGION, POSTAL CODE), G1, G3 MEDTRONIC IS SUBMITTING THIS REPORT TO COMPLY WITH FDA REPORTING REGULATIONS UNDER 21 CFR PARTS 4 AND 803. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION AND HAS PROVIDED AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY ¿DEFECTS¿ OR HAS ¿MALFUNCTIONED¿. THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REGULATORY REPORTING. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE THEM BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

    Description of Event or Problem · 0

    ACCORDING TO THE REPORTER, DURING A HET (HEMORRHOID ENERGY THERAPY) CASE, THE DOCTOR TREATED THE PATIENT'S HEMORRHOIDS AT 3 O'CLOCK, 7 O'CLOCK, AND 11 O'CLOCK POSITIONS. DURING THE PROCEDURE THEY NOTICED THAT THE TEMPERATURE OF THE FORCEPS WAS DECREASING SLOWER THAN USUAL. THEY INSTRUCTED DR. (B)(6) TO TAKE THE FORCEPS OUT OF THE PATIENT AFTER EACH TREATMENT UNTIL THE FORCEPS WENT BACK TO ROOM TEMPERATURE. THE PATIENT DID NOT CALL WITH ANY POST PROCEDURE COMPLICATIONS. HOWEVER, APPROXIMATELY 10 DAYS POST PROCEDURE, THE DOCTOR CALLED TO INFORM THAT THE PATIENT WENT TO THE ER (EMERGENCY ROOM) DUE TO BLEEDING FROM THE RECTUM.

    Description of Event or Problem · 0

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

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    344164 HET ELECTROSURGICAL, CUTTING & COAGULATION & ACCES GEI COVIDIEN MFG DC BOULDER 180-1022 10884521511132

    Patients

    Seq Age Sex Outcome Treatment
    1 Unknown Other| H